Menarini, Lunaphore Collaborate on Rapid Tissue Staining for IHC

Sep 10, 2018

|

NEW YORK (360Dx) – Lunaphore Technologies and A. Menarini Diagnostics today announced a strategic partnership to bring to market a new system that uses Lunaphore’s LabSat Frozen technology, an automated tissue staining system that aims to enable performing immunohistochemistry assays in a few minutes.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Menarini, Lunaphore Collaborate on Rapid Tissue Staining for IHC

To read the full story....

Breaking News

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

What's Popular?

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

Sponsorships